Hepatitis C and B seroprevalence in patients infected with the human immunodeficiency virus in psychiatric hospitals

被引:1
|
作者
Gabastou, JM
Chouaki, T
Zemir, A
Mangeot, J
Manuel, C
Cornel, E
DenisJacquot, N
Demaison, J
Mahuzier, G
Bourlioux, P
机构
来源
MEDECINE ET MALADIES INFECTIEUSES | 1996年 / 26卷 / 12期
关键词
HIV; HCV; HBV; syphilis; prevalence;
D O I
10.1016/S0399-077X(96)80115-6
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The aim of this retrospective study, carried out between January 1992 and April 1995 was to determine the prevalence and characteristics of infection by the hepatitis C virus for a population of HIV+ patients from five psychiatric hospitals in the Ile de France region. To this end, 117 HIV infected patients benefited from : a) a screening program for HCV, HBV, and syphilis antibodies and b) a dosage of transaminases. The associated risk factors were as follows: 64 % of HIV infected patients were drug addicts, 12 % were heterosexuals, 10 % were homosexuals, and 3 % had received a blood transfusion. The precise means of contamination was not established in 11 % of the cases. The prevalence of HIV was 71 % but varied according to the means of contamination. No correlation was found between HCV seropositivity and an increased level of transaminases, 80 % of patients were carriers of at least one hepatitis B marker antibody. The detection of the sole HBc antibody, in the absence of other HBV markers, appeared to be a good indirect marker of hepatitis C. Only 3 % of the patients were screened as responding well to vaccination against hepatitis B (isolated Ac HBs). 6 % of the patients were contaminated by all three viruses, HIV, HCV, and HBV. This study is the first to show, within the psychiatric sphere, that the prevalence of hepatitis C is considerably higher for HIV infected patients. Contamination through intravenous injection of drugs is the most likely cause of infection. A prospective follow up of HIV infected patients is therefore indispensable. Finally, the insufficient number of patients vaccinated against the hepatitis B virus should incite us to relaunch a vaccination programme in our hospital centers.
引用
收藏
页码:1169 / 1172
页数:4
相关论文
共 50 条
  • [41] Steatosis in human immunodeficiency virus and hepatitis C virus co-infected patients
    Murray, MP
    Marks, KM
    Talal, AH
    Gulick, RM
    Glesby, MJ
    Petrovic, LM
    [J]. LABORATORY INVESTIGATION, 2005, 85 : 284A - 284A
  • [42] Acute outbreak of hepatitis C in human immunodeficiency virus-infected patients
    Martinez-Rebollar, Maria
    Mallolas, Josep
    Perez, Inaki
    Gonzalez-Cordon, Ana
    Lonca, Montserrat
    Torres, Berta
    Rojas, Jhon-Fredy
    Monteiro, Polyana
    Blanco, Jose-Luis
    Martinez, Esteban
    Gatell, Jose-Maria
    Laguno, Montserrat
    [J]. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2015, 33 (01): : 3 - 8
  • [43] Hepatitis A in human immunodeficiency virus-infected patients
    Wallace, MR
    Hill, HE
    Tasker, SA
    Miller, LK
    [J]. CLINICAL INFECTIOUS DISEASES, 1998, 27 (03) : 651 - 653
  • [44] Interferon treatment for chronic hepatitis C in patients infected by the human immunodeficiency virus
    Soriano, V
    GarciaSamaniego, J
    Bravo, R
    Gonzalez, J
    Castro, A
    MartinezOdriozola, P
    Colmenero, M
    Carballo, E
    Suarez, D
    Castilla, J
    RodriguezPinero, FJ
    Moreno, A
    delRomero, J
    Pedreira, J
    GonzalezLahoz, J
    [J]. MEDICINA CLINICA, 1996, 106 (13): : 486 - 490
  • [45] Treatment of hepatitis C and anemia in human immunodeficiency virus-infected patients
    Dieterich, DT
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2002, 185 : S128 - S137
  • [46] High seroprevalence of parvovirus B19 among patients infected with human immunodeficiency virus
    Vernazza, PL
    Pfister, LA
    Siegl, G
    Cassinotti, P
    [J]. CLINICAL INFECTIOUS DISEASES, 1996, 22 (01) : 198 - 199
  • [47] Hepatitis B virus seroprevalence among human immunodeficiency virus infected men with antiretroviral therapy under universal infant hepatitis B immunization program
    Lin, Chia-Chun
    Lee, Yuan-Ti
    Lin, Kuan-Yin
    Tang, Hung-Jen
    Lee, Yi-Chien
    Liu, Chun-Eng
    Huang, Yu-Shan
    Lin, Shih-Ping
    Wang, Ning-Chi
    Hung, Chien-Ching
    Li, Chia-Wen
    Ko, Wen-Chien
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 50 : S160 - S161
  • [48] Prevalence of Hepatitis B virus and/or Hepatitis C virus co-infections in prisoners infected with the Human Immunodeficiency Virus
    Pontali, Emanuele
    Ferrari, Franco
    [J]. INTERNATIONAL JOURNAL OF PRISONER HEALTH, 2008, 4 (02) : 77 - +
  • [49] Seroprevalence of and Risk Factors Associated With Hepatitis B, Hepatitis C, and Human Immunodeficiency Virus Among Prisoners in Iran
    Pourahmad, Morteza
    Javady, Abbassali
    Karimi, Iraj
    Ataei, Behrooz
    Kassaeian, Nazila
    [J]. INFECTIOUS DISEASES IN CLINICAL PRACTICE, 2007, 15 (06) : 368 - 372